Piedmont Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,709
Closed -$294K 387
2020
Q1
$294K Buy
2,709
+120
+5% +$17.3K 0.01% 615
2019
Q4
$376K Buy
2,589
+319
+14% +$46.1K 0.01% 650
2019
Q3
$328K Buy
2,270
+82
+4% +$12K 0.01% 705
2019
Q2
$325K Sell
2,188
-181
-8% -$25.3K 0.01% 736
2019
Q1
$311K Buy
2,369
+122
+5% +$15K 0.01% 786
2018
Q4
$244K Buy
2,247
+509
+29% +$68.2K 0.01% 834
2018
Q3
$259K Buy
1,738
+346
+25% +$52.6K 0.01% 852
2018
Q2
$215K Buy
+1,392
New +$210K 0.01% 802
2017
Q1
Sell
-341
Closed -$37.6K 534
2016
Q4
$37.6K Buy
341
+338
+11,267% +$37.5K ﹤0.01% 473
2016
Q3
$412 Hold
3
﹤0.01% 507
2016
Q2
$390 Buy
+3
New +$323 ﹤0.01% 468

Other funds holding LH

Piedmont Investment Advisors's LH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Labcorp (LH) in Q2 2020, closing a stake of 2,709 shares — an estimated $294K sold.

Piedmont Investment Advisors first reported a position in LH in Q2 2016 and held it in 11 quarters. The position peaked at $376K in Q4 2019. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 2,709 Labcorp shares in Q2 2020, an estimated $294K.
  • Piedmont Investment Advisors first reported a position in Labcorp in Q2 2016 and held it in 11 quarters.
  • Piedmont Investment Advisors's Labcorp position peaked at $376K in Q4 2019.
  • 798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.